Corindus Vascular Robotics (CVRS) Misses Q4 EPS by 1c

Corindus Vascular Robotics (NYSE: CVRS) reported Q4 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $622 thousand versus the consensus estimate of $860 thousand.

For earnings history and earnings-related data on Corindus Vascular Robotics (CVRS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c